Deprescribing the Kt/V Target for Peritoneal Dialysis in the United States: The Path Toward Adopting International Standards for Dialysis Adequacy
J Am Soc Nephrol
.
2023 May 1;34(5):751-754.
doi: 10.1681/ASN.0000000000000101.
Epub 2023 Feb 14.
Authors
George Maliha
1
2
,
Eric D Weinhandl
3
4
,
Yuvaram N V Reddy
2
5
6
7
8
Affiliations
1
Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
2
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
3
Satellite Healthcare, San Jose, California.
4
Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota.
5
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
6
Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
7
ASN Quality Committee, American Society of Nephrology, Washington, District of Columbia.
8
ASN Home Dialysis Steering Committee, American Society of Nephrology, Washington, District of Columbia.
PMID:
36787755
PMCID:
PMC10125636
DOI:
10.1681/ASN.0000000000000101
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Deprescriptions*
Humans
Kidney Failure, Chronic*
Peritoneal Dialysis*
Renal Dialysis
United States
Grants and funding
K12 HS026372/HS/AHRQ HHS/United States